Related Experiment Video
Updated: Dec 28, 2025

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
Therapeutic management of stroke-like episodes varies from that of encephalitis
1Krankenanstalt Rudolfstiftung, Messerli Institute, Vienna, Austria.
Introduction:
Stroke-like episodes (SLEs) are typical cerebral manifestations of certain mitochondrial disorders (MIDs). They are characterised by a vasogenic edema in a non-vascular distribution. PATIENTS CONCERNS:: none DIAGNOSIS:: SLEs show up on cerebral MRI as stroke-like lesions (SLLs), characterised by vasogenic edema in a non-vascular distribution. SLLs expand in the acute stage and regress during the chronic stage. They show hyperperfusion in the acute stage and hypoperfusion in the chronic stage.
Interventions:
SLLs respond favorably to antiseizure drugs, to No-precursors, steroids, the ketogenic diet, and antioxidants.
Outcome:
SLLs end up as normal tissue, white matter lesion, grey matter lesion, cyst, laminar cortical necrosis, or the toenail sign.
Conclusions:
SLLs are a frequent manifestation of MIDs. They undergo dynamic changes in the acute and chronic stage. They need to be differentiated from ischemic stroke as they are differentially treated.
Insights
Stroke-like lesions (SLLs) in mitochondrial disorders (MIDs) present as vasogenic edema. These lesions dynamically change and require differentiation from ischemic stroke for appropriate treatment.
Area of Science:
- Neurology
- Mitochondrial Medicine
- Neuroimaging
Background:
- Stroke-like episodes (SLEs) are characteristic cerebral manifestations of mitochondrial disorders (MIDs).
- These episodes manifest as stroke-like lesions (SLLs) on cerebral MRI, defined by vasogenic edema in non-vascular distributions.
- SLLs exhibit dynamic changes, expanding in the acute phase and regressing in the chronic phase, with altered perfusion patterns.
Observation:
- SLLs exhibit dynamic changes, expanding in the acute phase and regressing in the chronic phase.
- Acute SLLs show hyperperfusion, while chronic SLLs demonstrate hypoperfusion on imaging.
- These lesions can evolve into various outcomes, including normal tissue, white or grey matter lesions, cysts, or laminar cortical necrosis.
Findings:
- SLLs are a common manifestation of MIDs.
- Treatment interventions such as antiseizure drugs, steroids, ketogenic diet, and antioxidants show favorable responses.
- Distinguishing SLLs from ischemic stroke is critical for appropriate management.
Implications:
- Understanding the distinct nature of SLLs in MIDs is essential for accurate diagnosis and treatment.
- The dynamic nature and varied outcomes of SLLs necessitate tailored therapeutic strategies.
- This research highlights the importance of neuroimaging in identifying and monitoring SLLs in mitochondrial disease patients.
Related Concept Videos
Myocarditis III: Medical Management
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Myocarditis IV: Nursing Management
Electroconvulsive Therapy

